Background: Autosomal recessive severe congenital neutropenia (SCN) has been associated with homozygous variants in the HAX1(HCLS1 Associated Protein X-1) gene. In this rare disease, ovarian insufficiency has been reported only in nine female patients in the literature. There is insufficient data on the gonadal function of patients with SCN due to HAX1 gene variant ( HAX1-SCN ) in childhood and the age of onset of premature ovarian insufficiency (POI) is unknown. The aim of this cross-sectional study was to evaluate the gonadal functions and pubertal development in pediatric patients with HAX1-SCN. Methods: Forty-five patients, including 24 females (median age 11.3 years, 1.5–31 years, 13 pubertal and 11 prepubertal), and 21 males (median age 9.5 years, 3–18.8 years, 7 pubertal and 14 prepubertal), followed in 7 centers, were included. POI is defined as a menstrual disturbance with increased follicle stimulating hormone (FSH) and low anti-Mullerian hormone (AMH). We classified prepubertal female patients as impending POI when they had low AMH and high FSH values, indicating impaired ovarian function. Results: A homozygous single nucleotide insertion (position 130-131insA) leading to a premature stop codon; p.Trp44*(c.132G>A) variant in HAX1 gene was detected in 42 (93.3%) affected individuals. Other homozygous variants were p.Arg86*(c.256C>T) and p.Glu60Aspfs*25(c.180delA). We detected elevated serum FSH levels in 10/11 (90.9%) of prepubertal female patients, supporting the diagnosis of impending POI, and in 12/13 (92.3%) of pubertal female patients, classifying them as POI. All female patients had low AMH levels. Male patients did not exhibit gonadal insufficiency. Conclusions: This is the first and largest case series covering early childhood to evaluate patients with HAX1-SCN for gonadal functions. It has been observed that pubertal girls develop POI, prepubertal girls are at increased risk for gonadal failure and male patients are not affected. Our results suggest that HAX1 has an important role in ovarian maturation and/or function. The genotype-phenotype relationship of these patients and the effect of clinical features of SCN on gonadal function should be further investigated.

Background: With the widespread use of hematopoietic stem cell transplantation (HSCT), long-term complications have come to the fore. The aim of this study is to determine the prevalence and risk factors of chronic kidney disease (CKD) developing in the long term in patients who underwent allogeneic HSCT in childhood and also to investigate the superiority of eGFR formulas. Methods: The present study evaluated CKD in patients undergoing allogeneic HSCT. We analyzed the 94 children who received allogeneic HSCT at the Ege University in İzmir between 2019 August and 2019 November. The patients were evaluated at least 2 years after transplantation. CKD was defined as a glomerular filtration rate (GFR)<90 mL/min/1.73 m2, using eGFR equations which are based on serum creatinine (SCr), cystatin C (CysC), and SCr plus CysC. Results: In our study, 9 (9.4%) according to Bedside Schwartz, 59 (76.6%) according to CKiD-eGFR-CysC and 20 (26%) patients according to CKiD-eGFR-SCr-CysC equation were evaluated as CKD. In cases evaluated as CKD according to CysC, early development of acute kidney injury (AKI), posttransplant cytomegalovirus (CMV) reactivation and being >10 years old during transplantation were found to be associated with the development of CKD. Conclusion: We may be delayed in detecting CKD by calculating SCr-based formulas in HSCT cases, which is a patient group where early diagnosis and treatment of CKD is very important.